Midregional proadrenomedullin for prediction of cardiovascular events in coronary artery disease: Results from the AtheroGene study

Clinical Chemistry

Volumn 58, Issue 1, 2012, Pages 226-236

  Wild, Philipp S ^a   Schnabel, Renate B ^a,b   Lubos, Edith ^a,b   Zeller, Tanja ^a,b   Sinning, Christoph R ^a,b   Keller, Till ^a,b   Tzikas, Stergios ^a   Lackner, Karl J ^c   Peetz, Dirk ^c   Rupprecht, Hans J ^d   Bickel, Christoph ^e   Morgenthaler, Nils G ^f   Papassotiriou, Jana ^f   Tiret, Laurence ^g   Münzel, Thomas ^a   Blankenberg, Stefan ^a,b  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b UNIVERSITY HEART CENTER HAMBURG   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d Gesundheits und Pflegezentrum Russelsheim   (Germany)

^e BUNDESWEHRZENTRALKRANKENHAUS KOBLENZ   (Germany)

^f THERMO FISHER SCIENTIFIC   (Germany)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; PROADRENOMEDULLIN;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; ATHEROGENESIS; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES CONTROL; DIABETES MELLITUS; FATALITY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; STABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; ADRENOMEDULLIN; AGED; ANGINA PECTORIS; BIOLOGICAL MARKERS; CORONARY ARTERY DISEASE; FEMALE; HUMANS; IMMUNOASSAY; KAPLAN-MEIER ESTIMATE; LUMINESCENT MEASUREMENTS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; RISK ASSESSMENT;

ANGINA;

EID: 84856077397     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2010.157842     Document Type: Article

References (40)

1. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, Eto T. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993;192:553-60. (Pubitemid 23227359)
2. Ichiki Y, Kitamura K, Kangawa K, Kawamoto M, Matsuo H, Eto T. Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FEBS Lett 1994;338:6-10. (Pubitemid 24047772)
3. Sugo S, Minamino N, Kangawa K, Miyamoto K, Kitamura K, Sakata J, et al. Endothelial cells actively synthesize and secrete adrenomedullin. Biochem Biophys Res Commun 1994;201:1160-6. (Pubitemid 24234212)
4. Sugo S, Minamino N, Shoji H, Kangawa K, Kitamura K, Eto T, Matsuo H. Production and secretion of adrenomedullin from vascular smooth muscle cells: augmented production by tumor necrosis factor-alpha. Biochem Biophys Res Commun 1994;203:719-26.
5. Kitamura K, Kangawa K, Eto T. Adrenomedullin and PAMP: discovery, structures, and cardiovascular functions. Microsc Res Tech 2002;57:3-13. (Pubitemid 34242539)
6. Parkes DG, May CN. Direct cardiac and vascular actions of adrenomedullin in conscious sheep. Br J Pharmacol 1997;120:1179-85. (Pubitemid 27122660)
7. Asakawa H, Nishikimi T, Suzuki T, Hara S, Tsubokou Y, Yagi H, et al. Elevation of two molecular forms of adrenomedullin in plasma and urine in patients with acute myocardial infarction treated with early coronary angioplasty. Clin Sci (Lond) 2001;100:117-26. (Pubitemid 32057816)
8. Kobayashi K, Kitamura K, Etoh T, Nagatomo Y, Takenaga M, Ishikawa T, et al. Increased plasma adrenomedullin levels in chronic congestive heart failure. Am Heart J 1996;131:994-8. (Pubitemid 26135766)
9. Sugo S, Minamino N, Shoji H, Kangawa K, Kitamura K, Eto T, Matsuo H. Interleukin-1, tumor necrosis factor and lipopolysaccharide additively stimulate production of adrenomedullin in vascular smooth muscle cells. Biochem Biophys Res Commun 1995;207:25-32.
10. Tsuruda T, Kato J, Kitamura K, Kuwasako K, Imamura T, Koiwaya Y, et al. Secretion of proadrenomedullin N-terminal 20 peptide from cultured neonatal rat cardiac cells. Life Sci 2001;69:239-45. (Pubitemid 32523080)
11. Chun TH, Itoh H, Saito T, Yamahara K, Doi K, Mori Y, et al. Oxidative stress augments secretion of endothelium-derived relaxing peptides, C-type natriuretic peptide and adrenomedullin. J Hypertens 2000;18:575-80. (Pubitemid 30303488)
12. Chun TH, Itoh H, Ogawa Y, Tamura N, Takaya K, Igaki T, et al. Shear stress augments expression of C-type natriuretic peptide and adrenomedullin. Hypertension 1997;29:1296-302. (Pubitemid 27233180)
13. Cormier-Regard S, Nguyen SV, Claycomb WC. Adrenomedullin gene expression is developmentally regulated and induced by hypoxia in rat ventricular cardiac myocytes. J Biol Chem 1998;273:17787-92. (Pubitemid 28355122)
14. Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994;90:195-203. (Pubitemid 24203680)
15. Nishikimi T, Yoshihara F, Mori Y, Kangawa K, Matsuoka H. Cardioprotective effect of adrenomedullin in heart failure. Hypertens Res 2003;26 Suppl:S121-7. (Pubitemid 36372327)
16. Niu P, Shindo T, Iwata H, Iimuro S, Takeda N, Zhang Y, et al. Protective effects of endogenous adrenomedullin on cardiac hypertrophy, fibrosis, and renal damage. Circulation 2004;109:1789-94. (Pubitemid 38500683)
17. Kawai J, Ando K, Tojo A, Shimosawa T, Takahashi K, Onozato ML, et al. Endogenous adrenomedullin protects against vascular response to injury in mice. Circulation 2004;109:1147-53. (Pubitemid 38332619)
18. Morgenthaler NG, Struck J, Alonso C, Bergmann A. Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay. Clin Chem 2005;51:1823-9. (Pubitemid 41368172)
19. Pio R, Martinez A, Unsworth EJ, Kowalak JA, Bengoechea JA, Zipfel PF, et al. Complement factor H is a serum-binding protein for adrenomedullin, and the resulting complex modulates the bioactivities of both partners. J Biol Chem 2001;276:12292-300.
20. Meeran K, O'Shea D, Upton PD, Small CJ, Ghatei MA, Byfield PH, Bloom SR. Circulating adrenomedullin does not regulate systemic blood pressure but increases plasma prolactin after intravenous infusion in humans: a pharmacokinetic study. J Clin Endocrinol Metab 1997;82:95-100. (Pubitemid 27021277)
21. Lewis LK, Smith MW, Yandle TG, Richards AM, Nicholls MG. Adrenomedullin(1-52) measured in human plasma by radioimmunoassay: plasma concentration, adsorption, and storage. Clin Chem 1998;44:571-7. (Pubitemid 28141354)
22. Yoshihara F, Ernst A, Morgenthaler NG, Horio T, Nakamura S, Nakahama H, et al. Midregional proadrenomedullin reflects cardiac dysfunction in haemodialysis patients with cardiovascular disease. Nephrol Dial Transplant 2007;22:2263-8. (Pubitemid 47244704)
23. Lim SC, Morgenthaler NG, Subramaniam T, Wu YS, Goh SK, Sum CF. The relationship between adrenomedullin, metabolic factors, and vascular function in individuals with type 2 diabetes. Diabetes Care 2007;30:1513-9. (Pubitemid 46871163)
24. Christ-Crain M, Morgenthaler NG, Struck J, Harbarth S, Bergmann A, Muller B. Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study. Crit Care 2005;9:R816-24.
25. Khan SQ, O'Brien RJ, Struck J, Quinn P, Morgenthaler N, Squire I, et al. Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study. J Am Coll Cardiol 2007;49:1525-32. (Pubitemid 46517963)
26. Rupprecht HJ, Blankenberg S, Bickel C, Rippin G, Hafner G, Prellwitz W, et al. Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease. Circulation 2001;104:25-31. (Pubitemid 32623285)
27. Blankenberg S, McQueen MJ, Smieja M, Pogue J, Balion C, Lonn E, et al. Comparative impact of multiple biomarkers and N-terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation 2006;114:201-8. (Pubitemid 44297113)
28. Katayama T, Nakashima H, Furudono S, Honda Y, Suzuki S, Yano K. Evaluation of neurohumoral activation (adrenomedullin, BNP, catecholamines, etc.) in patients with acute myocardial infarction. Intern Med 2004;43:1015-22. (Pubitemid 39619115)
29. Kohno M, Hanehira T, Kano H, Horio T, Yokokawa K, Ikeda M, et al. Plasma adrenomedullin concentrations in essential hypertension. Hypertension 1996;27:102-7. (Pubitemid 26020667)
30. Ishihara T, Yokota N, Hisanaga S, Fujimoto S, Hirayama N, Kato J, et al. Increased plasma levels of mature form of adrenomedullin in patients with chronic renal failure. Clin Nephrol 1999;52:119-23. (Pubitemid 29387168)
31. Kubo A, Kurioka H, Minamino N, Nishitani Y, Sato H, Nishino T, et al. Plasma and urinary levels of adrenomedullin in chronic glomerulonephritis patients with proteinuria. Nephron 1998;80:227-30. (Pubitemid 28458803)
32. Hirata Y, Mitaka C, Sato K, Nagura T, Tsunoda Y, Amaha K, Marumo F. Increased circulating adrenomedullin, a novel vasodilatory peptide, in sepsis. J Clin Endocrinol Metab 1996;81:1449-53. (Pubitemid 26118575)
33. Schnabel R, Lubos E, Rupprecht HJ, Espinola-Klein C, Bickel C, Lackner KJ, et al. B-type natriuretic peptide and the risk of cardiovascular events and death in patients with stable angina: results from the AtheroGene study. J Am Coll Cardiol 2006;47:552-8. (Pubitemid 43170843)
34. Blankenberg S, Tiret L, Bickel C, Peetz D, Cambien F, Meyer J, Rupprecht HJ. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation 2002;106:24-30. (Pubitemid 34747437)
35. Wollert KC, Kempf T, Peter T, Olofsson S, James S, Johnston N, et al. Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome. Circulation 2007;115:962-71. (Pubitemid 46328289)
36. Kragelund C, Gronning B, Kober L, Hildebrandt P, Steffensen R. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med 2005;352:666-75. (Pubitemid 40239214)
37. Richards AM, Nicholls MG, Yandle TG, Frampton C, Espiner EA, Turner JG, et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 1998;97:1921-9.
38. Richards AM, Doughty R, Nicholls MG, MacMahon S, Sharpe N, Murphy J, et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group. J Am Coll Cardiol 2001;37:1781-7. (Pubitemid 32499959)
39. Kobayashi K, Kitamura K, Hirayama N, Date H, Kashiwagi T, Ikushima I, et al. Increased plasma adrenomedullin in acute myocardial infarction. Am Heart J 1996;131:676-80. (Pubitemid 26119560)
40. Nagaya N, Nishikimi T, Uematsu M, Yoshitomi Y, Miyao Y, Miyazaki S, et al. Plasma adrenomedullin as an indicator of prognosis after acute myocardial infarction. Heart 1999;81:483-7. (Pubitemid 29234307)